BlackRock’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,250,023
| Closed | -$49.3M | – | 5257 |
|
|
2020
Q3 | $49.3M | Sell |
5,250,023
-314,515
| -6% | -$2.99M | ﹤0.01% | 2311 |
|
|
2020
Q2 | $42.6M | Sell |
5,564,538
-125,326
| -2% | -$959K | ﹤0.01% | 2353 |
|
|
2020
Q1 | $35.2M | Buy |
5,689,864
+118,424
| +2% | +$1.04M | ﹤0.01% | 2283 |
|
|
2019
Q4 | $67.8M | Buy |
5,571,440
+190,892
| +4% | +$2.09M | ﹤0.01% | 2180 |
|
|
2019
Q3 | $62.1M | Buy |
5,380,548
+77,936
| +1% | +$820K | ﹤0.01% | 2161 |
|
|
2019
Q2 | $53M | Buy |
5,302,612
+23,305
| +0.4% | +$251K | ﹤0.01% | 2287 |
|
|
2019
Q1 | $68M | Sell |
5,279,307
-194,164
| -4% | -$2.89M | ﹤0.01% | 2105 |
|
|
2018
Q4 | $83.1M | Buy |
5,473,471
+125,691
| +2% | +$2.39M | ﹤0.01% | 1933 |
|
|
2018
Q3 | $107M | Buy |
5,347,780
+110,771
| +2% | +$2.52M | ﹤0.01% | 1925 |
|
|
2018
Q2 | $102M | Buy |
5,237,009
+48,110
| +0.9% | +$1.06M | ﹤0.01% | 1923 |
|
|
2018
Q1 | $105M | Sell |
5,188,899
-299,640
| -5% | -$5.07M | 0.01% | 1819 |
|
|
2017
Q4 | $72.7M | Buy |
5,488,539
+200,205
| +4% | +$3.02M | ﹤0.01% | 2061 |
|
|
2017
Q3 | $97.6M | Buy |
5,288,334
+137,980
| +3% | +$2.57M | ﹤0.01% | 1871 |
|
|
2017
Q2 | $94.8M | Buy |
5,150,354
+154,942
| +3% | +$3.07M | 0.01% | 1832 |
|
|
2017
Q1 | $113M | Buy |
4,995,412
+4,988,054
| +67,791% | +$119M | 0.01% | 1701 |
|
|
2016
Q4 | $256K | Sell |
7,358
-70
| -0.9% | -$2.09K | ﹤0.01% | 1979 |
|
|
2016
Q3 | $182K | Buy |
7,428
+432
| +6% | +$10.8K | ﹤0.01% | 2224 |
|
|
2016
Q2 | $167K | Buy |
6,996
+2,697
| +63% | +$61.8K | ﹤0.01% | 2210 |
|
|
2016
Q1 | $101K | Buy |
4,299
+3,615
| +529% | +$85.8K | ﹤0.01% | 1988 |
|
|
2015
Q4 | $20K | Hold |
684
| – | – | ﹤0.01% | 2594 |
|
|
2015
Q3 | $28K | Hold |
684
| – | – | ﹤0.01% | 2198 |
|
|
2015
Q2 | $47K | Hold |
684
| – | – | ﹤0.01% | 2000 |
|
|
2015
Q1 | $38K | Hold |
684
| – | – | ﹤0.01% | 2066 |
|
|
2014
Q4 | $29K | Sell |
684
-38
| -5% | -$1.37K | ﹤0.01% | 2204 |
|
|
2014
Q3 | $23K | Hold |
722
| – | – | ﹤0.01% | 2267 |
|
|
2014
Q2 | $15K | Sell |
722
-3
| -0.4% | -$55 | ﹤0.01% | 2549 |
|
|
2014
Q1 | $14K | Hold |
725
| – | – | ﹤0.01% | 2548 |
|
|
2013
Q4 | $17K | Hold |
725
| – | – | ﹤0.01% | 2453 |
|
|
2013
Q3 | $16K | Hold |
725
| – | – | ﹤0.01% | 2391 |
|
|
2013
Q2 | $16K | Buy |
+725
| New | +$16K | ﹤0.01% | 2419 |
|
BlackRock's AMAG Position: Q4 2020 in Review
BlackRock sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 5,250,023 shares — an estimated $49.3M sold.
BlackRock first reported a position in AMAG in Q2 2013 and held it in 30 quarters. The position peaked at $113M in Q1 2017. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- BlackRock reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- BlackRock sold 5,250,023 AMAG Pharmaceuticals shares in Q4 2020, an estimated $49.3M.
- BlackRock first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 30 quarters.
- BlackRock's AMAG Pharmaceuticals position peaked at $113M in Q1 2017.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on BlackRock's 13F filing for Q4 2020, filed 5 Feb 2021.